Verano’s Zen Leaf Elizabeth and Lawrence Dispensaries Ready and Excited to Welcome New Jersey Personal Use Cannabis Customers on April 21

CHICAGO, April 15, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today celebrated the New Jersey Cannabis Regulatory Commission’s announcement that personal use cannabis sales will commence in the state on Thursday, April 21, 2022.

Verano is the sole cannabis company currently permitted to initiate personal use sales in New Jersey’s central region on April 21^st at its Zen Leaf Elizabeth (117 Spring St) and Lawrence Township (3256 Brunswick Pike) dispensary locations. The Company also operates Zen Leaf Neptune Township (2100 Route 66), a medical cannabis dispensary that will soon commence adult use sales, along with a state-of-the-art, 120,000 square foot cultivation and processing facility in Branchburg.

Quote from George Archos, Verano Founder and Chief Executive Officer:

“April 21, 2022 is a day that will be forever celebrated by New Jerseyans, marking the historic moment when the Garden State’s vote to embrace progress over cannabis prohibition became reality. Thanks to the residents of New Jersey, and the courageous leadership of Governor Murphy, Senator Scutari, the Cannabis Regulatory Commission, and the countless township and county commissioners statewide, cannabis will realize its full potential to make a lasting, positive impact on the state’s economy and society. On behalf of Verano and Zen Leaf, we are excited and ready to welcome the first personal use cannabis customers in the great state of New Jersey on April 21^st.”

Nationally, Verano’s active operations span 13 states, comprised of 95 dispensaries and 12 cultivation and processing facilities with more than 1 million square feet of cultivation capacity. Verano offers a wide range of premium cannabis products sold at its Zen Leaf New Jersey locations, including concentrates, edibles, vaporizers and flower. Customers may pre-order online at www.zenleafdispensaries.com for same day, in-store pick up, and the Company also offers home delivery for medical cannabis patients.

In conjunction with the launch of personal use cannabis sales, business hours at Zen Leaf’s Elizabeth and Lawrence Township locations will be Monday through Saturday, 8:00 a.m. – 10:00 p.m., and 10:00 a.m. – 9:00 p.m. on Sunday, with the first and last hour of business reserved exclusively for medical cannabis patients. Business hours for medical cannabis patients visiting the Company’s Zen Leaf Neptune Township dispensary are Monday through Saturday, 9:00 a.m. – 9:00 p.m., and 10:00 a.m. – 6:00 p.m. on Sunday.

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano^™, Avexia^™, Encore^™, and MÜV^™. Verano’s portfolio encompasses 15 U.S. states, with active operations in 13, including 12 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf^™ and MÜV^™, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.

Contacts:
Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
julianna.paterra@verano.com

Media
Verano
Steve Mazeika
Director, Communications
steve.mazeika@verano.com
312-348-4430

Forward Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements or information with respect to the Company’s position in the marketplace, and the Company’s operations. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risk factors discussed in the Company’s filings on SEDAR at www.sedar.com. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###